Yoshida O - Search Results

1

Potentiation of the sensitivity of renal cell carcinoma cells to TRAIL-mediated apoptosis by subtoxic concentrations of 5-fluorouracil.

Mizutani Y, Nakanishi H, Yoshida O, Fukushima M, Bonavida B, Miki T. Mizutani Y, et al. Among authors: yoshida o. Eur J Cancer. 2002 Jan;38(1):167-76. doi: 10.1016/s0959-8049(01)00339-2. Eur J Cancer. 2002. PMID: 11750847

2

Prognostic significance of thymidine kinase activity in bladder carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Kamoi K, Miki T. Mizutani Y, et al. Among authors: yoshida o. Cancer. 2002 Nov 15;95(10):2120-5. doi: 10.1002/cncr.10948. Cancer. 2002. PMID: 12412165 Free article.

3

Significance of thymidine kinase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nakao M, Miki T. Mizutani Y, et al. Among authors: yoshida o. J Urol. 2003 Feb;169(2):706-9. doi: 10.1097/01.ju.0000036473.23401.13. J Urol. 2003. PMID: 12544347

4

Significance of thymidylate synthase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nonomura M, Nakao M, Miki T. Mizutani Y, et al. Among authors: yoshida o. Clin Cancer Res. 2003 Apr;9(4):1453-60. Clin Cancer Res. 2003. PMID: 12684419

5

The significance of thymidine phosphorylase/platelet-derived endothelial cell growth factor activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Kawauchi A, Nakao M, Miki T. Mizutani Y, et al. Among authors: yoshida o. Cancer. 2003 Aug 15;98(4):730-6. doi: 10.1002/cncr.11570. Cancer. 2003. PMID: 12910516 Free article.

6

Significance of orotate phosphoribosyltransferase activity in renal cell carcinoma.

Mizutani Y, Wada H, Yoshida O, Fukushima M, Nakanishi H, Miki T. Mizutani Y, et al. Among authors: yoshida o. J Urol. 2004 Feb;171(2 Pt 1):605-10. doi: 10.1097/01.ju.0000107833.03488.d2. J Urol. 2004. PMID: 14713770

7

Prognostic significance of orotate phosphoribosyltransferase activity in bladder carcinoma.

Mizutani Y, Wada H, Fukushima M, Yoshida O, Nakanishi H, Li YN, Miki T. Mizutani Y, et al. Among authors: yoshida o. Cancer. 2004 Feb 15;100(4):723-31. doi: 10.1002/cncr.11955. Cancer. 2004. PMID: 14770427 Free article. Clinical Trial.

8

Enhanced susceptibility of c-myc antisense oligonucleotide-treated human renal cell carcinoma cells to lysis by peripheral blood lymphocytes.

Mizutani Y, Bonavida B, Fukumoto M, Yoshida O. Mizutani Y, et al. Among authors: yoshida o. J Immunother Emphasis Tumor Immunol. 1995 Feb;17(2):78-87. doi: 10.1097/00002371-199502000-00002. J Immunother Emphasis Tumor Immunol. 1995. PMID: 7647959

9

Enhanced susceptibility of cis-diamminedichloroplatinum-treated K562 cells to lysis by peripheral blood lymphocytes and lymphokine activated killer cells.

Mizutani Y, Bonavida B, Nio Y, Yoshida O. Mizutani Y, et al. Among authors: yoshida o. Cancer. 1993 Feb 15;71(4):1313-21. doi: 10.1002/1097-0142(19930215)71:4<1313::aid-cncr2820710424>3.0.co;2-#. Cancer. 1993. PMID: 7679609

10

Sensitization of human renal cell carcinoma cells to cis-diamminedichloroplatinum(II) by anti-interleukin 6 monoclonal antibody or anti-interleukin 6 receptor monoclonal antibody.

Mizutani Y, Bonavida B, Koishihara Y, Akamatsu K, Ohsugi Y, Yoshida O. Mizutani Y, et al. Among authors: yoshida o. Cancer Res. 1995 Feb 1;55(3):590-6. Cancer Res. 1995. PMID: 7834629

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

959 results

Search Page

Filters